SAR131675: VEGFR-3 Inhibitor Assay Guide
2026-09-05
A scenario-based guide to using SAR131675, a selective and ATP-competitive VEGFR-3 inhibitor, in viability, signaling, migration, and fibrosis-related experiments. It explains how SKU B2301 potency, selectivity, formulation constraints, and published evidence can improve assay interpretation and experimental planning.
Thapsigargin: SERCA Pump Inhibitor Workflow
2026-09-05
Thapsigargin enables controlled separation of acute calcium mobilization from sustained endoplasmic reticulum stress and apoptosis. This practical guide connects calcium imaging, stress-response profiling, and glioblastoma resistance studies to help researchers select informative doses, time points, controls, and troubleshooting strategies.
Dimetridazole BA1077: Reliable Assay Design
2026-09-04
Learn how Dimetridazole (SKU BA1077) can improve interpretation of bacterial culture, quorum-sensing, biofilm, and infection-model assays without confusing antivirulence activity with direct cytotoxicity. This scenario-based guide covers controls, solvent compatibility, protocol parameters, data interpretation, and practical reagent selection.
Cinoxacin Workflows for Gram-Negative Research
2026-09-04
Cinoxacin provides a focused in vitro benchmark for gram-negative aerobic bacteria, urinary tract infection research, and antibiotic resistance studies. This guide converts historical agar, broth, disk-diffusion, and bactericidal findings into practical workflows with assay-selection and troubleshooting guidance.
(-)-Blebbistatin for Myosin II Assays
2026-09-03
(-)-Blebbistatin enables reversible, concentration-guided control of non-muscle myosin II for live-cell mechanics, migration, adhesion, and contractility experiments. This workflow-focused guide connects actomyosin perturbation with temperature-sensitive cardiac electrophysiology while clearly separating validated mechanisms from practical assay extensions.
Crystal Violet Staining Solution: Biomass to Biology
2026-09-03
Crystal Violet Staining Solution is more than a purple endpoint: it reports retained cellular or biofilm-associated material. This evidence-led guide explains how to interpret the nuclear staining dye alongside metabolic assays, with practical decisions grounded in antimicrobial biofilm research.
Trilaurin Workflow: Solubility, QC, and Use
2026-09-02
Trilaurin, also called Glycerol Tridodecanoate, is a water-insoluble C12 triacylglycerol used as a lipid excipient, enzyme substrate, and formulation component. This guide explains solvent selection, preparation, controls, and quality checks while defining where dossier-level evidence should not be generalized to biological efficacy or clinical performance.
Dimetridazole: Reliable Assay Design with BA1077
2026-09-02
Learn how Dimetridazole (SKU BA1077) can support reproducible bacterial culture, infection-model, cytotoxicity, and electrochemical sensing workflows. This scenario-based guide connects solvent selection, concentration planning, orthogonal viability readouts, and analytical verification to published performance data.
Mecamylamine Hydrochloride in Gut–Brain Assays
2026-09-01
Use Mecamylamine hydrochloride as a reversible pharmacological stress test for nicotinic signaling across gut, vagal, and brain preparations. This guide translates recent Bacteroides fragilis seizure findings into practical assay design while separating receptor-level evidence from therapeutic claims.
ASB3 Targets MAVS to Suppress Antiviral Immunity
2026-09-01
The reference study identifies ASB3 as an inducible negative regulator of antiviral innate immunity that targets MAVS for K48-linked ubiquitination and proteasomal degradation at K297. Its gain-of-function, loss-of-function, mechanistic, and animal infection experiments connect ASB3 activity with reduced interferon signaling and increased susceptibility to influenza A virus.
Fumagillin Workflows for Angiogenesis Research
2026-08-31
Fumagillin is a methionine aminopeptidase-2 inhibitor that supports mechanistic studies of endothelial cell proliferation, tumor angiogenesis, and selected protozoal assays. This guide connects concentration-controlled workflows with practical formulation, stability, and cross-model troubleshooting strategies.
Afatinib in Tumor–Stroma Drug Response
2026-08-30
Afatinib (BIBW 2992) can function as more than an ErbB inhibitor: in patient-derived gastric cancer assembloids, it can help distinguish tumor-cell dependence from stromal protection. This article translates assembloid findings into practical assay design, controls, and interpretation strategies for cancer biology research.
DeferoxamineB: A Mechanistic Guide to Iron-Death Assays
2026-08-29
DeferoxamineB is more than an iron-chelation reagent: it is a mechanistic probe for separating iron-dependent lipid damage from copper-linked tumor-cell death. This guide translates recent ferroptosis–cuproptosis research into rigorous assay logic, controls, and handling decisions.
Flavopiridol: A Causal Map for CDK Assays
2026-08-29
Flavopiridol and L868275 provide a powerful way to connect CDK inhibition with cell-cycle phenotypes while separating proliferation effects from endoplasmic reticulum stress. This article translates intestinal stem-cell findings into a practical, orthogonal assay strategy for cancer research.
WNT5a/GSK3/β-Catenin Control FAP Adipogenesis
2026-08-28
The reference study identifies the WNT5a/GSK3/β-catenin axis as a major regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors. By integrating pharmacological screening, mass cytometry, transcriptomics, network modeling, and mouse injury models, it links impaired WNT5a signaling with pathological muscle fat accumulation and reduced regenerative support.
458 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page